Cargando…

Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease

Background: Kawasaki disease (KD) is a form of febrile vasculitis that primarily occurs in children. It can cause inflammation of the coronary arteries, which leads to aneurysms. The pathogenesis of coronary arteries may be associated with apoptosis or pyroptosis mediated by caspases activity, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Kuang-Che, Yang, Ya-Ling, Lo, Mao-Hung, Cai, Xin-Yuan, Guo, Mindy Ming-Huey, Kuo, Ho-Chang, Huang, Ying-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620614/
https://www.ncbi.nlm.nih.gov/pubmed/34829381
http://dx.doi.org/10.3390/diagnostics11112035
_version_ 1784605262609383424
author Kuo, Kuang-Che
Yang, Ya-Ling
Lo, Mao-Hung
Cai, Xin-Yuan
Guo, Mindy Ming-Huey
Kuo, Ho-Chang
Huang, Ying-Hsien
author_facet Kuo, Kuang-Che
Yang, Ya-Ling
Lo, Mao-Hung
Cai, Xin-Yuan
Guo, Mindy Ming-Huey
Kuo, Ho-Chang
Huang, Ying-Hsien
author_sort Kuo, Kuang-Che
collection PubMed
description Background: Kawasaki disease (KD) is a form of febrile vasculitis that primarily occurs in children. It can cause inflammation of the coronary arteries, which leads to aneurysms. The pathogenesis of coronary arteries may be associated with apoptosis or pyroptosis mediated by caspases activity, but this idea has not been discussed much in KD. Materials and Methods: We enrolled 236 participants in this study. In the Affymetrix GeneChip(®) Human Transcriptome Array 2.0 study, there were 18 KD patients analyzed prior to receiving intravenous immunoglobulin (IVIG) treatment, at least 3 weeks after IVIG treatment, and 36 non-KD control subjects. We also recruited 24 KD patients prior to receiving IVIG treatment, at least 3 weeks after IVIG treatment, and 24 non-KD control subjects for Illumina HumanMethylation450 BeadChip study. A separate cohort of 134 subjects was analyzed to validate real-time quantitative PCR. Results: The mRNA levels of caspase-1, -3, -4, and -5 were significantly increased in KD patients compared with control subjects (p < 0.05). After administration of IVIG, the expression of these genes decreased considerably. Of particular note, the methylation status of the CpG sites of the caspase-4 and -5 genes demonstrated significant opposite tendencies between the KD patients and controls. Furthermore, compared with patients who responded to IVIG, refractory KD patients had a lower expression of the caspase-3 gene prior to IVIG treatment. Conclusion: Our study is the first to report the upregulation of pyroptotic caspase-1, -4, and -5 in peripheral leukocytes of KD patients. Moreover, the expression of caspase-3 may be associated with IVIG resistance in KD.
format Online
Article
Text
id pubmed-8620614
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86206142021-11-27 Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease Kuo, Kuang-Che Yang, Ya-Ling Lo, Mao-Hung Cai, Xin-Yuan Guo, Mindy Ming-Huey Kuo, Ho-Chang Huang, Ying-Hsien Diagnostics (Basel) Article Background: Kawasaki disease (KD) is a form of febrile vasculitis that primarily occurs in children. It can cause inflammation of the coronary arteries, which leads to aneurysms. The pathogenesis of coronary arteries may be associated with apoptosis or pyroptosis mediated by caspases activity, but this idea has not been discussed much in KD. Materials and Methods: We enrolled 236 participants in this study. In the Affymetrix GeneChip(®) Human Transcriptome Array 2.0 study, there were 18 KD patients analyzed prior to receiving intravenous immunoglobulin (IVIG) treatment, at least 3 weeks after IVIG treatment, and 36 non-KD control subjects. We also recruited 24 KD patients prior to receiving IVIG treatment, at least 3 weeks after IVIG treatment, and 24 non-KD control subjects for Illumina HumanMethylation450 BeadChip study. A separate cohort of 134 subjects was analyzed to validate real-time quantitative PCR. Results: The mRNA levels of caspase-1, -3, -4, and -5 were significantly increased in KD patients compared with control subjects (p < 0.05). After administration of IVIG, the expression of these genes decreased considerably. Of particular note, the methylation status of the CpG sites of the caspase-4 and -5 genes demonstrated significant opposite tendencies between the KD patients and controls. Furthermore, compared with patients who responded to IVIG, refractory KD patients had a lower expression of the caspase-3 gene prior to IVIG treatment. Conclusion: Our study is the first to report the upregulation of pyroptotic caspase-1, -4, and -5 in peripheral leukocytes of KD patients. Moreover, the expression of caspase-3 may be associated with IVIG resistance in KD. MDPI 2021-11-03 /pmc/articles/PMC8620614/ /pubmed/34829381 http://dx.doi.org/10.3390/diagnostics11112035 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kuo, Kuang-Che
Yang, Ya-Ling
Lo, Mao-Hung
Cai, Xin-Yuan
Guo, Mindy Ming-Huey
Kuo, Ho-Chang
Huang, Ying-Hsien
Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
title Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
title_full Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
title_fullStr Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
title_full_unstemmed Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
title_short Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
title_sort increased expression of pyroptosis in leukocytes of patients with kawasaki disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620614/
https://www.ncbi.nlm.nih.gov/pubmed/34829381
http://dx.doi.org/10.3390/diagnostics11112035
work_keys_str_mv AT kuokuangche increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease
AT yangyaling increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease
AT lomaohung increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease
AT caixinyuan increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease
AT guomindyminghuey increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease
AT kuohochang increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease
AT huangyinghsien increasedexpressionofpyroptosisinleukocytesofpatientswithkawasakidisease